98291771 - ENGINEERING THE EXTRAORDINARY

Information

  • Trademark
  • 98291771
  • Serial Number
    98291771
  • Filing Date
    November 30, 2023
    5 months ago
  • Transaction Date
    February 21, 2024
    2 months ago
  • Status Date
    November 30, 2023
    5 months ago
  • Location Date
    February 21, 2024
    2 months ago
  • Status Code
    630
  • Attorney Docket Number
    T88853194US1
    Attorney Name
    Blaine A. Page
  • Owners
Mark Drawing Code
4000
Mark Identification
ENGINEERING THE EXTRAORDINARY
Case File Statements
  • GS0051: Allograft material, namely, human allograft bone and tissue used for surgical implants; bio-absorbable bone implants comprised of living tissue; biological tissue grafts; biological bone tissue intended for subsequent implant; implants comprising living tissue; natural biomaterials for augmentation of bone and tissue for medical purposes; prepared collagenous biological dermal tissue intended for subsequent grafting, transplantation and deep tissue support during plastic surgery and reconstructive surgery in injectable and non-injectable form; medical preparations for the treatment, reconstruction, re-contouring and repair of damaged human tissue; skin grafts; bone wax for use in surgical procedures; bone cement containing opacifiers for medical use, bone cement for surgical use; bone cement for orthopedic use; medical personal lubricants used with surgical instruments for improved action during surgical procedures; gauze; dressings for surgery; medical and surgical dressings; injectable bioresorbable nasal dressing for medical purposes; topical human tissue adhesive preparations for medical purposes and medical adhesives for topically binding human internal tissue; surgical and wound dressings for human and animal use, gauze and medical adhesive tapes; gauze, surgical bandages; gauze and surgical bandages featuring embedded radio-frequency identification (RFID) tags; surgical implants comprised of living tissue for aortic heart valves; non-adhesive medical preparations, injectable as a liquid which then solidifies for use, for the treatment of vascular disorders; blood for medical purposes in the nature of standardized blood samples in cartridge form used as controls to verify performance of blood coagulation monitoring equipment; Pharmaceuticals for the treatment of nose and sinus and respiratory-related conditions and symptoms; pharmaceutical preparations used for the treatment of polyps and inflammation; steroids
Case File Event Statements
  • 2/21/2024 - 2 months ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/30/2023 - 5 months ago
    1 - NEW APPLICATION ENTERED Type: NWAP